Skip to content

Therapeutic proposal for treatment of hip Tendinopathies

Therapeutic proposal for treatment of hip Tendinopathies

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-399cyrr
Enrollment
Unknown
Registered
2021-06-02
Start date
2021-02-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tendinopathy

Interventions

Experimental Group: 40 adults diagnosed with gluteal tendinopathy will receive an exercise program of 8 weeks and 16 sessions, with gradually progressive traction load in minimal hip adduction positio
E02.760.169.063.500.387

Sponsors

Centro Universitário de Brasília - UniCEUB
Lead Sponsor
Hospital Ortopédico de Medicina Especializada
Collaborator

Eligibility

Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Adults diagnosed with gluteal tendinopathy through clinical and magnetic resonance imaging and who had persistent pain in the lateral region of the hip above 3 on the analogue pain scale (VAS) for more than 3 months will be admitted to the study

Exclusion criteria

Exclusion criteria: Patients diagnosed with joint pathologies such as coxarthrosis, avascular osteonecrosis of the femoral head, pain from spinal disorders or any arthropathy detected on radiographic examination were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Evaluation of pain reduction verified by visual analogue pain scale and measured by pressure algometer. ;Evaluation of improvement in hip function measured by the Harris Hip Score and Hip Outcome Score questionnaires.

Secondary

MeasureTime frame
Strength improvement, verified by e-last 02863-17-10410, portable, bluetooth dynamometer (Technology BR 10201400007232-2). ;Increased range of motion verified using a universal goniometer.

Countries

Brazil

Contacts

Public ContactTatiane Rosa
tmorelati@gmail.com+55-61-991625545

Outcome results

None listed

Source: REBEC (via WHO ICTRP)